Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth

Information

DOI:
https://doi.org/10.1002/14651858.CD008136.pub3Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 08 September 2015see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:
  1. Cochrane Pregnancy and Childbirth Group

Copyright:
  1. Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Japaraj Robert Peter

    Correspondence to: Department of Obstetrics and Gynecology, Hospital Raja Permaisuri Bainun, Ipoh, Malaysia

    [email protected]

  • Jacqueline J Ho

    Department of Paediatrics, Penang Medical College, Penang, Malaysia

  • Jayabalan Valliapan

    Department of Obstetrics and Gynecology, Ipoh Hospital, Ipoh, Malaysia

  • Subramaniam Sivasangari

    Clinical Research Center, Penang Hospital, Georgetown, Malaysia

Contributions of authors

The updated review was prepared by Jacqueline J Ho and J Robert Peter with input from V Jayabalan and help from S Sivasangari.

Sources of support

Internal sources

  • Hospital Raja Permaisuri Bainun Ipoh, Malaysia.

  • Penang Medical College, Penang, Malaysia.

External sources

  • South East Asia‐Optimising Reproductive and Child Health In Developing Countries (SEA ORCHID Project), Malaysia.

    See http://www.seaorchid.org/

  • UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization, Switzerland.

Declarations of interest

None known.

Acknowledgements

SEA‐ORCHID project.

We thank Nasreen Aflaifel for her help in the production of the 'Summary of findings' table. Nasreen Aflaifel's work was financially supported by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization. The named authors alone are responsible for the views expressed in this publication.

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Pregnancy and Childbirth. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2015 Sep 08

Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth

Review

Japaraj Robert Peter, Jacqueline J Ho, Jayabalan Valliapan, Subramaniam Sivasangari

https://doi.org/10.1002/14651858.CD008136.pub3

2012 Jul 11

Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth

Review

Japaraj Robert Peter, Jacqueline J Ho, Jayabalan Valliapan, Subramaniam Sivasangari

https://doi.org/10.1002/14651858.CD008136.pub2

2009 Oct 07

Symphysial fundal height measurement (SFH) in pregnancy for detecting abnormal fetal growth

Protocol

Japaraj Robert Peter, Jacqueline J Ho, Jayabalan Valliapan, Subramaniam Sivasangari

https://doi.org/10.1002/14651858.CD008136

Differences between protocol and review

The methods have been updated in accordance with the latest version of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011) and Pregnancy and Childbirth standard methods text. We added the words 'or clinical palpation' to the objectives to broaden it so that it matched the description given in the section on the types of interventions. A 'Summary of findings' table has been incorporated for the 2015 update.

Keywords

MeSH

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figures and Tables -
Figure 1

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figures and Tables -
Figure 2

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Tape measurement versus clinical palpation, Outcome 1 Neonatal detection of small‐for‐dates.
Figures and Tables -
Analysis 1.1

Comparison 1 Tape measurement versus clinical palpation, Outcome 1 Neonatal detection of small‐for‐dates.

Comparison 1 Tape measurement versus clinical palpation, Outcome 2 Perinatal death.
Figures and Tables -
Analysis 1.2

Comparison 1 Tape measurement versus clinical palpation, Outcome 2 Perinatal death.

Comparison 1 Tape measurement versus clinical palpation, Outcome 3 Neonatal hypoglycaemia.
Figures and Tables -
Analysis 1.3

Comparison 1 Tape measurement versus clinical palpation, Outcome 3 Neonatal hypoglycaemia.

Comparison 1 Tape measurement versus clinical palpation, Outcome 4 Admission to neonatal nursery.
Figures and Tables -
Analysis 1.4

Comparison 1 Tape measurement versus clinical palpation, Outcome 4 Admission to neonatal nursery.

Comparison 1 Tape measurement versus clinical palpation, Outcome 5 Admission to neonatal nursery because of intrauterine growth restriction.
Figures and Tables -
Analysis 1.5

Comparison 1 Tape measurement versus clinical palpation, Outcome 5 Admission to neonatal nursery because of intrauterine growth restriction.

Comparison 1 Tape measurement versus clinical palpation, Outcome 6 Induction of labour.
Figures and Tables -
Analysis 1.6

Comparison 1 Tape measurement versus clinical palpation, Outcome 6 Induction of labour.

Comparison 1 Tape measurement versus clinical palpation, Outcome 7 Caesarean section.
Figures and Tables -
Analysis 1.7

Comparison 1 Tape measurement versus clinical palpation, Outcome 7 Caesarean section.

Summary of findings for the main comparison. Tape measurement compared with clinical palpation for pregnancy for detecting abnormal fetal growth

Tape measurement compared with clinical palpation for pregnancy for detecting abnormal fetal growth

Patient or population: Pregnant women with singleton fetuses who were of 20 weeks' gestation and above.
Settings: Denmark
Intervention: Tape measurement
Comparison: Clinical palpation

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

clinical palpation

Tape measurement

Neonatal detection of small‐for‐dates

Study population

RR 1.32
(0.92 to 1.90)

1639
(1 RCT)

⊕⊕⊝⊝
LOW 1,2

57 per 1000

76 per 1000
(53 to 109)

Moderate

58 per 1000

76 per 1000
(53 to 109)

Neonatal detection of large‐for‐gestational age

The study did not have data on this outcome.

Perinatal mortality

Study population

RR 1.25
(0.38 to 4.07)

1639
(1 RCT)

⊕⊕⊝⊝
LOW 4

6 per 1000

7 per 1000
(2 to 24)

Moderate

6 per 1000

8 per 1000
(2 to 24)

Intrauterine death

The study did not have data on this outcome.

Caesarean section

Study population

RR 0.72
(0.31 to 1.67)

1639
(1 RCT)

⊕⊝⊝⊝
VERY LOW 1,3

16 per 1000

11 per 1000
(5 to 26)

Moderate

16 per 1000

11 per 1000
(5 to 26)

Neurodevelopmental outcome in childhood

The study did not have address this outcome.

Admission to neonatal nursery

Study population

RR 1.06
(0.70 to 1.61)

1639
(1 RCT)

⊕⊕⊝⊝
LOW 1,2

50 per 1000

53 per 1000
(35 to 81)

Moderate

50 per 1000

53 per 1000
(35 to 81)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1One study with unclear risk of bias

2Wide CI crossing the line of no effect

3One small study with few events and wide CI crossing the line of no effect

4 Only one small study

Figures and Tables -
Summary of findings for the main comparison. Tape measurement compared with clinical palpation for pregnancy for detecting abnormal fetal growth
Comparison 1. Tape measurement versus clinical palpation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Neonatal detection of small‐for‐dates Show forest plot

1

1639

Risk Ratio (M‐H, Fixed, 95% CI)

1.32 [0.92, 1.90]

2 Perinatal death Show forest plot

1

1639

Risk Ratio (M‐H, Fixed, 95% CI)

1.25 [0.38, 4.07]

3 Neonatal hypoglycaemia Show forest plot

1

85

Risk Ratio (M‐H, Fixed, 95% CI)

1.10 [0.47, 2.58]

4 Admission to neonatal nursery Show forest plot

1

1639

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.70, 1.61]

5 Admission to neonatal nursery because of intrauterine growth restriction Show forest plot

1

1639

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.42, 2.15]

6 Induction of labour Show forest plot

1

1639

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.45, 1.58]

7 Caesarean section Show forest plot

1

1639

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.31, 1.67]

Figures and Tables -
Comparison 1. Tape measurement versus clinical palpation